News

News

2024
2023
2022
2021

Back number

2023

Dec. 25, 2023 Press Release: Sysmex Expands Sales of Its Reagents for Blood-based Amyloid β Testing to Europe
Dec. 21, 2023 Press Release: Sysmex Makes Megakaryon Corporation into a Subsidiary, Aiming at Accelerating Efforts in the Field of Regenerative and Cellular Medicine
- Towards the Early Commercialization of Human iPS Cell-Derived Platelet Preparations -
Dec. 20, 2023 Press Release: Sysmex Obtains Insurance Coverage for Its Immunoassay Reagent “HISCL™ M2BPGi™-Qt Assay Kit” for Quantitative Measurement of Hepatic Fibrosis Progression from Blood Samples
- Planned for Domestic Launch in February 2024, with Subsequent Introduction Overseas -
Dec. 14, 2023 Press Release: Sysmex and Fujirebio Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay
Dec. 12, 2023 Group Company News: Regulatory Approval Application Filed for the Use of the hinotori™ Surgical Robot System in Respiratory Surgery (Medicaroid)
Dec. 12, 2023 Information: Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Eighth Consecutive Year
Dec. 05, 2023 Press Release: Sysmex to Reinforce IVD Instrument Production to Support Total Solutions in Clinical Testing
- Expansion of Subsidiary's Manufacturing Factory Ensures Stable Global Supply and Enhanced Laboratory Productivity - (PDF：249KB)
Nov. 30, 2023 Press Release: Sysmex and Fujirebio Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration
Nov. 13, 2023 Information: Sysmex Publishes the Sysmex Report 2023 (Integrated Report) and the Sysmex Sustainability Data Book 2023
Nov. 10, 2023 Information: Implementing the Group-wide Unified Social Contribution Activity, the “Sysmex Gives Back Campaign”
Nov. 09, 2023 Information: Sysmex receives the highest rating of GOLD in the “Pride Index”, for its efforts related to sexual and gender minorities, for the second year in row
Nov. 08, 2023 Press Release: Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2024
Nov. 08, 2023 Press Release: Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2023 (PDF：235KB)
Nov. 08, 2023 Press Release: Announcement Regarding Introduction of Stock-Granting Compensation Plan (ESOP Trust) (PDF：245KB)
Nov. 07, 2023 Press Release: AlliedCel, a Joint Venture Between Sysmex and JCR Pharmaceuticals, Has Acquired a New Pipeline to Promote the Early Social Implementation of Regenerative Medicine Products
- Securing the Manufacturing and Sales License for Regenerative Medicine Products Developed by JUNTEN BIO -
Oct. 31, 2023 Information: Sysmex Receives “Minister of Education, Culture, Sports, Science, and Technology Prize” and Two Other Prizes at “Kinki Local Commendation for Inventions” in 2023
Oct. 20, 2023 Information: Sysmex Group Promotes “PINKTOBER,” a Breast Cancer Awareness Campaign
Oct. 16, 2023 Press Release: Sysmex Obtains ISO 30414 Certification for Human Capital Reporting
- Implementing Human Capital Management to Achieve Sustainable Increase in Corporate Value -
Oct. 12, 2023 Press Release: Sysmex Establishes New Open Innovation Hub “Healthcare Science Hub Tokyo”
- High-flexibility R&D hub for accelerating creative collaboration with various partners -
Oct. 11, 2023 Group Company News: Demonstration of Remote Surgery Using the hinotori™ Surgical Robot System Successfully Performed Between Singapore and Japan (Medicaroid)
Oct. 10, 2023 Press Release: Sysmex and Fujirebio Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay
Sep. 29, 2023 Information: Sysmex Brand Concept Movie Has Been Released
Sep. 20, 2023 Group Company News: Medicaroid Receives Regulatory Approval of Health Science Authority in Singapore for the hinotori™ Surgical Robot System (Medicaroid)
Aug. 30, 2023 Press Release: Sysmex’s PrismGuide™ IRD Panel System Receives Insurance Coverage as Japan’s First Gene Panel Testing System for Inherited Retinal Dystrophy
– Supporting Personalized Medicine Based on the Causative Genes of Intractable Diseases –
Aug. 30, 2023 Press Release: Sysmex’s OncoGuide™ NCC Oncopanel System Receives Insurance Coverage as a Companion Diagnostic for Futibatinib, a Treatment for Advanced Biliary Tract Cancer
Aug. 29, 2023 Press Release: Sysmex Begins Supplying Reagents for U.S. Based Laboratory Developed Test (LDT) Measuring Amyloid Beta (Aβ) in Blood
Aug. 08, 2023 Press Release: Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2024
Aug. 04, 2023 Information: Sysmex Again Selected for Inclusion in All ESG Indices adopted by the Government Pension Investment Fund (GPIF)
Aug. 03, 2023 Press Release: Sysmex Expands Long-Term Alliance with Roche
Jul. 27, 2023 Press Release: Project on the Utilization of Caresphere™, a Network Solution to Support Laboratory Testing Quality Control for the Republic of Ghana, Selected by METI for a Publicly Solicited Project
- Sysmex Launches a Feasibility Study on Using DX to Improve the Quality of Laboratory Testing in African Countries -
Jun. 29, 2023 Press Release: Our Views and Policy Regarding Investment Unit Reduction (PDF：129KB)
Jun. 27, 2023 Group Company News: OGT announces commercial partnership with Applied Spectral Imaging (OGT)
Jun. 26, 2023 Press Release: Sysmex Launches World's First Point-of-Care Testing System in Europe to Detect Antimicrobial Susceptibility in Just 30 Minutes
- By Revolutionizing Conventional Clinical Workflow, Our Diagnostic Technology Confronts the Global Threat of Antimicrobial Resistance (AMR) -
Jun. 22, 2023 Press Release: Sysmex Launches an Assay Kit to Identify Amyloid Beta (Aβ) Accumulation in the Brain, a Cause of Alzheimer’s Disease, Using a Small Amount of Blood
- Measurement of Plasma Aβ Using the Automated Immunoassay System HISCL™-5000/HISCL™-800 -
Jun. 05, 2023 Press Release: Sysmex Obtains Manufacturing and Marketing Approval for its PrismGuide™ IRD Panel System as Japan’s First Gene Panel Testing System for Inherited Retinal Dystrophy
- Contributing to Improving the QOL of Patients by Supporting Personalized Diagnosis Based on Causative Genes -
May. 18, 2023 Press Release: Sysmex Launches Clinical Flow Cytometry System in Japan
- Realizing Higher Efficiency and Standardization of Flow Cytometry (FCM) Testing -
May. 11, 2023 Press Release: Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2023
May. 11, 2023 Press Release: Sysmex Announces Changes from Financial Forecasts and Year-End Dividend (Commemorative Dividend) for the Fiscal Year Ended March 31, 2023 (PDF：186KB)
May. 11, 2023 Press Release: Announcement of Executive Change (PDF：140KB)
May. 11, 2023 Press Release: Sysmex Group Formulates a Long-Term Corporate Strategy and Mid-Term Management Plan
- Starting a New Challenge for the Next Decade -
May. 11, 2023 Press Release: Sysmex Formulates “Sysmex Eco-Vision 2033”
- Recognizing the relationship between the environment and health, we will collaboratively create innovative solutions that will advance the realization of a circular society -
May. 08, 2023 Group Company News: Regulatory Approval Application Filed with the Health Sciences Authority in Singapore for the “hinotori™ Surgical Robot System” (Medicaroid)
Apr. 17, 2023 Press Release: Sysmex to Establish New Manufacturing Base in India
- Creating a Manufacturing Structure in India to Support Sustainable Growth -
Apr. 14, 2023 Group Company News: Sysmex Inostics and Genomic Testing Cooperative Form Partnership to Accelerate Therapeutic Discovery and Development (Sysmex Inostics)
Mar. 27, 2023 Group Company News: AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC (Riken Genesis)
Mar. 16, 2023 Group Company News: Medicaroid Announces Top Management Changes (Medicaroid)
Mar. 15, 2023 Press Release: Sysmex Receives Approval for a Partial Change to the OncoGuide™ NCC Oncopanel System as a Companion Diagnostic to Futibatinib for Biliary Tract Cancer
Mar. 14, 2023 Group Company News: OGT first to achieve IVDR-certification for FISH probes (OGT)
Mar. 09, 2023 Press Release: Announcement of Organizational and Personnel Changes (PDF：200KB)
Mar. 08, 2023 Press Release: Sysmex and Siemens Healthineers Establish Global Agreement to Supply Hemostasis Instruments and Reagents as OEMs
Feb. 09, 2023 Press Release: Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
Feb. 07, 2023 Press Release: Notice of Changes in Representative Directors